Skip to main content
. Author manuscript; available in PMC: 2023 May 14.
Published in final edited form as: Urology. 2018 Apr 13;128:62–65. doi: 10.1016/j.urology.2018.04.001

Table 2.

Clinical performance characteristics

Detection of Any Cancer at Biopsy
Parameter Value 95% CI
 
Sensitivity 74.1% 63.1%−83.1%
Specificity 60.0% 51.1%−68.5%
Disease prevalence 38.4% N/A
PPV 53.6% 47.4%−59.6%
 NPV 78.8% 71.5%−84.6%

Detection of High-grade Cancer at Biopsy

Sensitivity 77.8% 57.7%−91.4%
Specificity 52.7% 45.2%−60.1%
Disease prevalence 12.8% N/A
PPV 19.4% 15.8%−23.7%
NPV 94.2% 88.7%−97.1%

CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value.